Daniel L. Wolf

1.2k total citations
25 papers, 759 citations indexed

About

Daniel L. Wolf is a scholar working on Cellular and Molecular Neuroscience, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Daniel L. Wolf has authored 25 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Surgery and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Daniel L. Wolf's work include Cardiac Arrest and Resuscitation (5 papers), Neuropeptides and Animal Physiology (5 papers) and Cardiac Valve Diseases and Treatments (4 papers). Daniel L. Wolf is often cited by papers focused on Cardiac Arrest and Resuscitation (5 papers), Neuropeptides and Animal Physiology (5 papers) and Cardiac Valve Diseases and Treatments (4 papers). Daniel L. Wolf collaborates with scholars based in United States, Spain and Mexico. Daniel L. Wolf's co-authors include Edward D. Hall, J. Scott Mohrland, John S. Althaus, Javier López, Ana Revilla, Isidre Vilacosta, J. Alberto San Román, Cristina Sarriá, Charles E. Geyer and John D. Hainsworth and has published in prestigious journals such as Cancer, Brain Research and Journal of neurosurgery.

In The Last Decade

Daniel L. Wolf

25 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel L. Wolf United States	13	229	187	165	158	143	25	759
Francesco Perna Italy	17	155 0.7×	307 1.6×	89 0.5×	74 0.5×	177 1.2×	37	1.1k
Lotte Jensen Denmark	14	128 0.6×	139 0.7×	21 0.1×	92 0.6×	121 0.8×	19	684
Adina Huţanu Romania	15	95 0.4×	212 1.1×	61 0.4×	52 0.3×	112 0.8×	87	695
M Brönnegård Sweden	19	101 0.4×	143 0.8×	48 0.3×	79 0.5×	203 1.4×	26	1.1k
E. Ventura Italy	17	52 0.2×	334 1.8×	45 0.3×	184 1.2×	164 1.1×	77	1.1k
László Pótó Hungary	14	47 0.2×	65 0.3×	98 0.6×	219 1.4×	159 1.1×	40	733
D Seidel Germany	13	65 0.3×	87 0.5×	77 0.5×	149 0.9×	69 0.5×	64	619
Maria D. Hurtado United States	19	60 0.3×	59 0.3×	79 0.5×	283 1.8×	160 1.1×	69	993
Heidi Ehrentraut Germany	15	79 0.3×	137 0.7×	55 0.3×	62 0.4×	256 1.8×	27	865

Countries citing papers authored by Daniel L. Wolf

Since Specialization

Citations

This map shows the geographic impact of Daniel L. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Wolf more than expected).

Fields of papers citing papers by Daniel L. Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Wolf. The network helps show where Daniel L. Wolf may publish in the future.

Co-authorship network of co-authors of Daniel L. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Wolf. A scholar is included among the top collaborators of Daniel L. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Wolf. Daniel L. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolf, Daniel L., et al.. (2024). What is Spanish regulation on the application of artificial intelligence to medicine like?. Humanities and Social Sciences Communications. 11(1). 2 indexed citations

Cervero, Miguel, Daniel L. Wolf, Pablo Ryan, et al.. (2022). Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial. Frontiers in Pharmacology. 13. 18 indexed citations

Wolf, Daniel L., Isidre Vilacosta, J. Alberto San Román, et al.. (2011). Infective Endocarditis in Octogenarian Patients. Revista Española de Cardiología (English Edition). 64(4). 329–333. 12 indexed citations

Wolf, Daniel L., et al.. (2010). [Laparoscopic radical hysterectomy with lymphatic mapping and sentinel lymph node biopsy in early cervical cancer].. PubMed. 78(7). 345–51. 2 indexed citations

Wolf, Daniel L., et al.. (2009). [Laparoscopy for staging and treatment of cervical cancer].. PubMed. 77(5). 213–8. 1 indexed citations

Herreros, B., et al.. (2009). Hemorragia digestiva alta en mujer de 81 años. Gastroenterología y Hepatología. 33(1). 30–32. 1 indexed citations

Vilacosta, Isidre, J. Alberto San Román, Paloma Aragoncillo, et al.. (2007). Síndrome coronario agudo en la endocarditis infecciosa. Revista Española de Cardiología. 60(1). 24–31. 63 indexed citations

Vilacosta, Isidre, J. Alberto San Román, Paloma Aragoncillo, et al.. (2007). Acute Coronary Syndrome in Infective Endocarditis. Revista Española de Cardiología (English Edition). 60(1). 24–31. 71 indexed citations

Wolf, Daniel L., et al.. (2003). Pharmacokinetics and Renal Effects of Cidofovir with a Reduced Dose of Probenecid in HIV‐Infected Patients with Cytomegalovirus Retinitis. The Journal of Clinical Pharmacology. 43(1). 43–51. 37 indexed citations

10.

Rothenberg, Mace L., John V. Cox, Russell F. DeVore, et al.. (1999). A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma. Cancer. 85(4). 786–795. 162 indexed citations

11.

Arnold, J. Malcolm O., et al.. (1994). Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest pain. International Journal of Cardiology. 44(3). 203–215. 5 indexed citations

12.

Jungbluth, Gail L., et al.. (1992). Clinical pharmacology of nicorandil in patients with congestive heart failure. Clinical Pharmacology & Therapeutics. 52(5). 496–503. 7 indexed citations

13.

Giles, Thomas D., Ileana L. Piña, Antonio C. Quiroz, et al.. (1992). Hemodynamic and Neurohumoral Responses to Intravenous Nicorandil in Congestive Heart Failure in Humans. Journal of Cardiovascular Pharmacology. 20(4). 572–578. 19 indexed citations

14.

Binkley, Philip F., Robert Cody, Melvin L. Moeschberger, et al.. (1990). Hemodynamic effects of oral nicorandil in congestive heart failure. The American Journal of Cardiology. 65(20). 1361–1367. 20 indexed citations

15.

Hall, Edward D., et al.. (1987). Beneficial effects of the κ opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury. Brain Research. 435(1-2). 174–180. 66 indexed citations

16.

Hall, Edward D. & Daniel L. Wolf. (1987). Post-Traumatic Spinal Cord Ischemia: Relationship to Injury Severity and Physiological Parameters. PubMed. 4(1). 15–25. 17 indexed citations

17.

Hall, Edward D. & Daniel L. Wolf. (1986). A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia. Journal of neurosurgery. 64(6). 951–961. 176 indexed citations

18.

Young, Gerald A., Daniel L. Wolf, & Naim Khazan. (1982). Relationships between blood ethanol levels and ethanol-induced changes in cortical EEG power spectra in the rat. Neuropharmacology. 21(7). 721–723. 7 indexed citations

19.

Young, Gerald A., Daniel L. Wolf, George F. Steinfels, & Naim Khazan. (1981). Morphine challenges in levo-alpha-acetylmethadol (LAAM) post-addict rats. Life Sciences. 28(13). 1523–1527. 4 indexed citations

20.

Wolf, Daniel L., Gerald A. Young, & Naim Khazan. (1981). Comparison between ethanol-induced and slow-wave sleep synchronous EEG activity utilizing spectral analysis. Neuropharmacology. 20(7). 687–692. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact